CA
NZ
UK
AU
IND
US
…
Pro Medicus Limited, a healthcare informatics company, provides medical imaging software and services to hospitals, imaging centers, and health care groups in Australia, Europe, and North America. The company offers Visage RIS, an enterprise-class radiology information system for patient registration, billing, scheduling, typing, HL7 integration, financial reporting, picture archive and communication system (PACS) integration, digital dictation, and voice recognition integration; and Visage RIS/PACS, a solution for imaging needs of organizations. It also provides Visage 7 Enterprise Imaging Platform, a healthcare imaging software for radiologists, physicians, and clinicians for access and visualization capability comprising rapidly viewing 2-D, 3-D, and 4-D medical images, as well as PACS, digital imaging software, training, installation, and professional services and support products; and Visage Ease, a native mobile application for access to medical imaging results stored on a Visage 7 server from iOS devices, including iPad, iPhone, and iTouch. In addition, the company offers Visage Ease Pro for interpreting diagnostic imaging studies; and Promedicus.net, an e-health offering. Pro Medicus Limited was incorporated in 1983 and is headquartered in Richmond, Australia.
Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website
A unique technical analysis driven score developed by Kalkine showing momentum in stock prices based on select technical indicators identified.
Pro Medicus Ltd develops and sells enterprise medical imaging and radiology visualization software and services to hospitals and imaging centers worldwide. Long-term growth drivers include expansion in the US and other international markets, recurring subscription licensing and rising demand for advanced imaging workflow and analytics; investors may find the company attractive for its niche market position, recurring revenue model and high software margins.
Material risks include customer concentration and execution risk in scaling operations, competitive pressure from larger healthcare IT vendors, and sensitivity to healthcare spending cycles and currency movements.
Note: The summary and risk score provided above is created by AI and should not be construed as a recommendation of Kalkine.
| Breakdown | 2026-06-30 | 2025-06-30 | 2024-06-30 | 2023-06-30 | 2022-06-30 |
|---|---|---|---|---|---|
| Type | yearly | yearly | yearly | yearly | yearly |
| Date | 2026-06-30 | 2025-06-30 | 2024-06-30 | 2023-06-30 | 2022-06-30 |
| Income before tax | 377.52M | 163.31M | 116.50M | 86.13M | 63.08M |
| Net income | 265.34M | 115.22M | 82.79M | 60.65M | 44.44M |
| Selling general administrative | - | 36.28M | 30.38M | 24.07M | 15.40M |
| Selling and marketing expenses | - | 3.74M | 2.89M | 2.52M | 1.95M |
| Gross profit | 211.15M | 212.60M | 122.24M | 124.24M | 92.94M |
| Reconciled depreciation | - | 7.24M | 8.51M | 7.93M | 7.32M |
| Ebit | 196.12M | 157.61M | 112.18M | 83.76M | 62.33M |
| Ebitda | 204.18M | 164.85M | 120.69M | 91.69M | 69.64M |
| Depreciation and amortization | 8.06M | 7.24M | 8.51M | 7.93M | 7.32M |
| Operating income | 196.12M | 157.61M | 112.18M | 84.08M | 61.31M |
| Other operating expenses | 65.57M | 55.29M | 49.25M | 40.12M | 30.10M |
| Interest expense | - | 1.94M | 1.12M | 0.39M | 0.65M |
| Tax provision | - | 48.09M | 33.70M | 25.48M | 18.64M |
| Interest income | - | 7.56M | 4.83M | 2.43M | 0.65M |
| Net interest income | - | 7.56M | 4.83M | 2.43M | 0.65M |
| Income tax expense | 112.17M | 48.09M | 33.70M | 25.48M | 18.64M |
| Total revenue | 261.69M | 212.91M | 161.43M | 124.79M | 93.40M |
| Total operating expenses | 15.03M | 54.98M | 48.95M | 40.48M | 30.61M |
| Cost of revenue | 50.54M | 0.31M | 39.19M | 0.54M | 0.47M |
| Total other income expense net | 181.40M | 5.70M | 4.32M | -0.07M | 0.10M |
| Net income from continuing ops | - | 115.22M | 82.79M | 60.65M | 44.44M |
| Net income applicable to common shares | - | 115.22M | 82.79M | 60.65M | 44.44M |
| Breakdown | 2026-06-30 | 2025-06-30 | 2024-06-30 | 2023-06-30 | 2022-06-30 |
|---|---|---|---|---|---|
| Type | yearly | yearly | yearly | yearly | yearly |
| Date | 2026-06-30 | 2025-06-30 | 2024-06-30 | 2023-06-30 | 2022-06-30 |
| Total assets | 610.14M | 338.70M | 257.43M | 202.13M | 157.05M |
| Intangible assets | 22.08M | 20.77M | 20.07M | 21.35M | 22.29M |
| Other current assets | 5.12M | 6.58M | 1.89M | 0.78M | 0.45M |
| Total liab | 159.22M | 81.74M | 69.70M | 63.36M | 55.32M |
| Total stockholder equity | 450.92M | 256.96M | 187.73M | 138.78M | 101.73M |
| Deferred long term liab | - | - | - | 2.36M | 1.47M |
| Other current liab | 27.75M | 21.31M | 15.21M | 16.56M | 14.48M |
| Common stock | 49.60M | 34.73M | 23.65M | 1.96M | 1.96M |
| Capital stock | - | 34.73M | 23.65M | 1.96M | 1.96M |
| Retained earnings | 440.02M | 239.46M | 173.36M | 127.12M | 92.58M |
| Other liab | - | - | - | 31.31M | 26.78M |
| Other assets | - | - | 0.00M | 12.45M | 47.19M |
| Cash | 146.48M | 174.54M | 60.06M | 91.25M | 63.66M |
| Total current liabilities | 52.25M | 43.14M | 34.56M | 30.85M | 26.86M |
| Current deferred revenue | 22.63M | 19.11M | 17.05M | 12.60M | 10.13M |
| Net debt | -144.25M | -172.28M | -57.99M | -89.40M | -61.38M |
| Short term debt | 0.77M | 1.32M | 0.55M | 0.65M | 0.60M |
| Short long term debt total | 2.23M | 2.25M | 2.07M | 1.85M | 2.28M |
| Other stockholder equity | - | - | - | -129.07M | -94.53M |
| Property plant equipment | - | - | - | 2.19M | 2.60M |
| Total current assets | 356.09M | 280.09M | 206.56M | 163.79M | 119.82M |
| Long term investments | - | 7.34M | 7.34M | - | - |
| Net tangible assets | - | - | - | 117.43M | 79.44M |
| Short term investments | 104.14M | 34.65M | 95.36M | 30.25M | 26.90M |
| Net receivables | 100.35M | 64.23M | 49.20M | 39.88M | 27.44M |
| Inventory | - | 0.10M | 0.05M | 0.06M | 0.08M |
| Accounts payable | 1.09M | 1.41M | 1.74M | 1.03M | 1.64M |
| Accumulated other comprehensive income | -38.70M | -17.23M | -9.28M | 9.70M | 7.20M |
| Non currrent assets other | 11.57M | 3.94M | 0.04M | 2.60M | 1.47M |
| Non current assets total | 254.04M | 58.61M | 50.86M | 38.34M | 37.23M |
| Capital lease obligations | - | 2.25M | 2.07M | 1.85M | 2.28M |
| Long term debt total | - | - | - | 1.20M | 1.68M |
| Breakdown | 2026-06-30 | 2025-06-30 | 2024-06-30 | 2023-06-30 | 2022-06-30 |
|---|---|---|---|---|---|
| Type | yearly | yearly | yearly | yearly | yearly |
| Date | 2026-06-30 | 2025-06-30 | 2024-06-30 | 2023-06-30 | 2022-06-30 |
| Investments | - | -6.58M | -73.28M | -7.56M | -8.53M |
| Change to liabilities | - | - | - | 7.14M | 8.10M |
| Total cashflows from investing activities | -21.28M | -6.58M | -78.07M | -7.56M | -16.91M |
| Net borrowings | - | - | - | -0.57M | -0.51M |
| Total cash from financing activities | -75.55M | -57.62M | -39.84M | -27.53M | -23.31M |
| Change to operating activities | - | - | - | 0.27M | 0.35M |
| Net income | 265.34M | 115.22M | 82.79M | 60.65M | 44.44M |
| Change in cash | 38.99M | 47.42M | -31.19M | 27.59M | 21.62M |
| Begin period cash flow | 107.49M | 60.06M | 91.25M | 63.66M | 42.04M |
| End period cash flow | 146.48M | 107.49M | 60.06M | 91.25M | 63.66M |
| Total cash from operating activities | 136.52M | 111.33M | 86.78M | 62.53M | 61.58M |
| Depreciation | 8.06M | - | 8.51M | 0.83M | 0.81M |
| Other cashflows from investing activities | - | -2.59M | -63.86M | -1.11M | 0.65M |
| Dividends paid | 64.78M | -49.11M | -36.55M | 26.11M | 18.79M |
| Change to inventory | - | -0.05M | 0.01M | 0.02M | -0.04M |
| Change to account receivables | -33.56M | -16.18M | -9.99M | -13.48M | -3.59M |
| Sale purchase of stock | -10.14M | -7.85M | -2.77M | -0.84M | -4.02M |
| Other cashflows from financing activities | -0.63M | -0.65M | -0.52M | -0.57M | -0.51M |
| Change to netincome | - | - | - | -0.24M | 0.40M |
| Capital expenditures | 0.44M | 7.38M | 6.69M | 6.45M | 9.02M |
| Change in working capital | 33.41M | -13.13M | -8.45M | -13.46M | -3.63M |
| Stock based compensation | - | - | - | 1.23M | 0.03M |
| Other non cash items | -170.29M | 124.46M | 86.72M | 1.05M | 16.32M |
| Free cash flow | 136.08M | 103.95M | 80.08M | 56.09M | 52.55M |
Sector: Healthcare Industry: Health Information Services
|
Stock Name
|
Change
(AUD) |
Price
(AUD) |
Trailing
PE (x) |
Forward
PE (x) |
Price Sales
TTM (x) |
Price to Book Value (x)
|
Enterprise Value
to Revenue (x) |
Enterprise Value
to EBITDA (x) |
|---|---|---|---|---|---|---|---|---|
| PME Pro Medicus Ltd |
1.15 0.71% |
162.15 | 64.69 | 89.29 | 65.34 | 37.37 | 63.47 | 81.35 |
| AYA ARTRYA Ltd |
-0.24 6.30% |
3.57 | - | - | 23230.33 | 8.10 | 20004.93 | 0.33 |
| CGS Cogstate Ltd |
-0.06 1.78% |
3.31 | 36.00 | 28.17 | 9.16 | 6.93 | 6.33 | 19.23 |
| EIQ Echoiq Ltd |
-0.05 8.47% |
0.54 | - | - | 5395.50 | 40.77 | 5059.22 | -8.27 |
| ALC Alcidion Group Ltd |
- -% |
0.10 | - | 1.23 | 2.68 | 1.49 | 2.75 | 18.06 |
Pro Medicus Limited, a healthcare informatics company, provides medical imaging software and services to hospitals, imaging centers, and health care groups in Australia, Europe, and North America. The company offers Visage RIS, an enterprise-class radiology information system for patient registration, billing, scheduling, typing, HL7 integration, financial reporting, picture archive and communication system (PACS) integration, digital dictation, and voice recognition integration; and Visage RIS/PACS, a solution for imaging needs of organizations. It also provides Visage 7 Enterprise Imaging Platform, a healthcare imaging software for radiologists, physicians, and clinicians for access and visualization capability comprising rapidly viewing 2-D, 3-D, and 4-D medical images, as well as PACS, digital imaging software, training, installation, and professional services and support products; and Visage Ease, a native mobile application for access to medical imaging results stored on a Visage 7 server from iOS devices, including iPad, iPhone, and iTouch. In addition, the company offers Visage Ease Pro for interpreting diagnostic imaging studies; and Promedicus.net, an e-health offering. Pro Medicus Limited was incorporated in 1983 and is headquartered in Richmond, Australia.
| Name | Title | Year Born |
|---|---|---|
| Dr. Sam Aaron Hupert M.B.B.S., M.D. | Co-Founder, CEO, MD & Exec. Director | NA |
| Mr. Anthony Barry Hall B.Sc., B.Sc.(Hons), M.Sc. | Co-Founder, Technology Director & Exec. Director | NA |
| Mr. Clayton James Hatch CPA, B.Comm, CPA | CFO & Company Sec. | NA |
| Dr. Malte Westerhoff | GM of Europe & Global CTO | NA |
| Mr. Brad Levin | GM of North America & Global Head of Marketing | NA |
| Mr. Sean Lambright | Global Head of Sales - Visage Imaging Inc | NA |
| Ms. Teresa Gschwind | Global Head of Customer Service of Visage Imaging Inc. | NA |
| Dr. Sam Aaron Hupert M.B.B.S., M.D. | Co-Founder, CEO, MD & Executive Director | NA |
| Mr. Anthony Barry Hall B.Sc., B.Sc.(Hons), M.Sc. | Co-Founder, Technology Director & Executive Director | NA |
| Mr. Clayton James Hatch B.Comm, CPA, CPA | Chief Financial Officer | NA |
Disclaimer - (*)This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on an ‘as is’ basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.
Download a free report with stock ideas and industry insights for general information.
Download Free Report Now →
Basic Materials
+0.18%
Communication Services
+0.02%
Consumer Cyclical
+0.43%
Consumer Defensive
+0.03%
Energy
-0.27%
Financial Services
+0.32%
Financials
-0.23%
Healthcare
-0.17%
Industrials
+0.45%
Real Estate
-0.02%
Technology
+0.20%
Utilities
+0.20%
Note: Daily price change (%) by sector excluding stocks with +/-90% daily price change. Companies above $500 million market capitalization are considered.
Portfolio
Watchlist
Please wait processing your request...